Strategic Partnership between Formedics and Elsevier Unveiled

Author: Logan Wright Updated: 05-20-2025 08:12 AM

Formedics Partners with Elsevier for Innovative Solutions

Formedics, a prominent healthcare professional collaboration platform, has announced an exciting partnership with Elsevier, a leader in scientific information and decision support. This collaboration aims to enhance strategic execution and sales solutions for over 20 medical societies around the globe.

New Avenues for Advertising and Engagement

Through this partnership, Formedics will facilitate new advertising opportunities within these medical societies, implementing data-driven digital strategies designed for increased peer engagement and collaboration. This includes precision targeting, tailored content solutions, and unique programs involving Key Opinion Leaders and Digital Opinion Leaders. Furthermore, Formedics will take charge of media sales for peer-reviewed journals in various specialties, offering both print and digital advertising, along with sponsored content and digital solutions.

Enhancing Healthcare with Advanced Technologies

This partnership is not just about expanding advertising reach; it also allows Elsevier to develop AI-enabled solutions that significantly benefit researchers and healthcare professionals alike. By leveraging advanced technologies, this collaboration strives to propel innovations in clinical research and drug discovery.

CEO Insights: Revolutionizing Healthcare Engagement

Greg Jackson, CEO of Formedics, expressed enthusiasm about this partnership, stating, "Our vision is to revolutionize healthcare engagement. Our deep experience in creating platforms that promote healthcare professional discussions will empower Elsevier to concentrate on strategic innovations that enhance healthcare outcomes." This aligns with the overarching goal of advancing medical practice and patient care through collaborative learning.

About Formedics, LLC

Formedics serves as a vital ecosystem where healthcare professionals can connect, collaborate, and learn from leading experts. The platform harnesses the potential of digital, point-of-care, and live event channels to effectively engage physicians. Launched in 2024, Formedics combines the strengths of multiple established entities creating a rich landscape for healthcare professional education.

About Elsevier

As a global leader in advanced information and decision support, Elsevier plays a crucial role in advancing both science and healthcare. The company has been dedicated to facilitating vital research and decision-making for more than 140 years, employing 9,500 individuals, including 2,300 technologists, who support researchers, healthcare professionals, and educators worldwide. Their extensive journal and reference book catalog, featuring prominent titles, underscores their commitment to advancing knowledge and innovation in various fields.

Frequently Asked Questions

What is the focus of the partnership between Formedics and Elsevier?

The partnership centers on providing strategic and sales solutions for over 20 global medical societies, enhancing healthcare professional engagement.

What types of advertising opportunities will Formedics enable?

Formedics will implement data-driven digital strategies for advertising, precision targeting, and customized content solutions.

How will this collaboration advance healthcare?

Through AI-enabled solutions, the collaboration aims to support researchers and healthcare professionals in clinical research and drug discovery.

Who is Greg Jackson?

Greg Jackson is the CEO of Formedics, advocating for innovations in healthcare engagement through collaborative platforms.

When was Formedics founded?

Formedics was founded in 2024 and integrates the expertise of several established entities in the healthcare education sector.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.